Seaport Therapeutics, Inc. (NasdaqGS: SPTX)
Health Care · Pharmaceuticals · US
$18.17
-4.97% today · -8.4% 1Y
Seaport Therapeutics, Inc. (NasdaqGS: SPTX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $972.65M and employs 58 people.
Over the last twelve months the share price has lost 8.4%, trading between 14.85 and 28.38.
Tweenvest scores Seaport Therapeutics, Inc. across four factors: quality 51/100, value 100/100. Its strongest factor is value.
SPTX price history
Key figures
- Market cap
- $972.65M
- Revenue (TTM)
- —
- P/E
- -12.99
- EPS
- -10.04
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $28.38
- 52-week low
- $14.85
- Avg volume (3M)
- —
- Shares outstanding
- 53.53M
- Employees
- 58
- Next earnings
- —
About Seaport Therapeutics, Inc.
Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinical trials, focused on creating groundbreaking treatments for neuropsychiatric conditions. The company is primarily engaged in tackling disorders like depression and anxiety, utilizing its unique Glyph technology. This exclusive platform is engineered to allow for oral administration of drugs, circumventing initial metabolic processing in the liver, and thereby reducing the risk of liver enzyme elevations, hepatotoxicity, and other potential adverse reactions. Every therapeutic agent in their pipeline incorporates this advanced platform, with all research and development efforts exclusively dedicated to neuropsychiatric applications. Founded in 2024 and situated in Boston, Massachusetts, the company connects with medical professionals and influential experts across the healthcare and neuropsychiatric sectors.
- ISIN
- US81221K1088
- Founded
- 2024
- Listed since
- May 1, 2026
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Aarti Pharmalabs LimitedNSEI: AARTIPHARM | $985.98M | Rs1,015.90 | +2.95% |
| Procter & Gamble Health LimitedBSE: 500126 | $983.71M | Rs5,534.70 | +0.57% |
| Guangxi Wuzhou Zhongheng Group Co., LtdSHSE: 600252 | $982.61M | CN¥2.07 | -2.36% |
| HARBIN GLORIA PHARMACEUTICALS Co., LTDSZSE: 002437 | $978.70M | CN¥2.93 | -3.62% |
| KPC Pharmaceuticals,Inc.SHSE: 600422 | $948.05M | CN¥8.36 | -1.07% |
| Mega Lifesciences Public Company LimitedSET: MEGA | $942.06M | ฿36.60 | 0.00% |
| SSY Group LimitedSEHK: 2005 | $936.24M | HK$2.54 | +0.79% |
| China Animal Husbandry Industry Co., Ltd.SHSE: 600195 | $934.70M | CN¥6.11 | +0.49% |